Insider Chris Francis plans WVE (NASDAQ: WVE) sale under Rule 144
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Chris Francis has filed a notice of proposed share sales under Rule 144 for Wave Life Sciences (symbol WVE). The filing covers 1,870 ordinary shares to be sold through Morgan Stanley Smith Barney LLC on or about 02/09/2026 on NASDAQ, with an aggregate market value of 25,151.50 and 187,693,059 ordinary shares outstanding.
The 1,870 shares were acquired on 02/08/2026 through restricted stock unit vesting from the issuer as equity compensation. In the past three months, Francis has already sold 441,031 ordinary shares on 12/08/2025 for gross proceeds of 6,427,084.96 and 9,375 ordinary shares on 01/02/2026 for 150,260.10.
Positive
- None.
Negative
- None.
FAQ
What does the WVE Rule 144 filing by Chris Francis disclose?
The filing discloses that Chris Francis plans to sell 1,870 WVE ordinary shares under Rule 144. These shares were acquired via restricted stock unit vesting on 02/08/2026 as equity compensation from the issuer, with planned sales through Morgan Stanley Smith Barney LLC on NASDAQ.